Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NMDA Receptors in the Central Nervous System
Kasper B. Hansen, Feng Yi, Riley E. Perszyk, et al.
Methods in molecular biology (2017), pp. 1-80
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Structure, function, and allosteric modulation of NMDA receptors
Kasper B. Hansen, Feng Yi, Riley E. Perszyk, et al.
The Journal of General Physiology (2018) Vol. 150, Iss. 8, pp. 1081-1105
Open Access | Times Cited: 462
Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases
Adam Armada‐Moreira, Joana I. Gomes, Carolina Campos Pina, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 226
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 53
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Todd D. Gould, Carlos A. Zarate, Scott M. Thompson
The Annual Review of Pharmacology and Toxicology (2018) Vol. 59, Iss. 1, pp. 213-236
Open Access | Times Cited: 117
Regulation of NMDA glutamate receptor functions by the GluN2 subunits
Marta Vieira, Xuan Ling Hilary Yong, Katherine W. Roche, et al.
Journal of Neurochemistry (2020) Vol. 154, Iss. 2, pp. 121-143
Open Access | Times Cited: 111
Magnesium and Pain
Hyun‐Jung Shin, Hyo‐Seok Na, Sang-Hwan Do
Nutrients (2020) Vol. 12, Iss. 8, pp. 2184-2184
Open Access | Times Cited: 103
Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 60
Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101838-101838
Closed Access | Times Cited: 23
Expanding Role of NMDA Receptor Antagonists in the Management of Pain
Denise Kreutzwiser, Qutaiba A. Tawfic
CNS Drugs (2019) Vol. 33, Iss. 4, pp. 347-374
Open Access | Times Cited: 74
Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression
Yu Yang, Weina Ju, Haining Zhang, et al.
Frontiers in Behavioral Neuroscience (2018) Vol. 12
Open Access | Times Cited: 67
Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse
Joseph T. Coyle, W. Brad Ruzicka, Darrick T. Balu
American Journal of Psychiatry (2020) Vol. 177, Iss. 12, pp. 1119-1128
Open Access | Times Cited: 61
Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N -methyl- d -aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children
Magdalini Sachana, Alexandra Rolaki, Anna Bal‐Price
Toxicology and Applied Pharmacology (2018) Vol. 354, pp. 153-175
Open Access | Times Cited: 60
Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors
Feng Yi, Subhrajit Bhattacharya, Charles M. Thompson, et al.
The Journal of Physiology (2019) Vol. 597, Iss. 22, pp. 5495-5514
Open Access | Times Cited: 54
Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients
Leiv Otto Watne, C. Pollmann, Bjørn Erik Neerland, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 2
Open Access | Times Cited: 35
Structural insights into NMDA receptor pharmacology
Changping Zhou, N. Tajima
Biochemical Society Transactions (2023) Vol. 51, Iss. 4, pp. 1713-1731
Open Access | Times Cited: 19
Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Eva-Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 17
Edaravone dexborneol attenuates cognitive impairment in a rat model of vascular dementia by inhibiting hippocampal oxidative stress and inflammatory responses and modulating the NMDA receptor signaling pathway
Hui Guo, Haodong Li, Zhisheng Jia, et al.
Brain Research (2024) Vol. 1833, pp. 148917-148917
Open Access | Times Cited: 6
Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay
Mohamed R. Elnagar, Anne B. Walls, Gouda K. Helal, et al.
European Journal of Pharmacology (2018) Vol. 826, pp. 106-113
Closed Access | Times Cited: 49
N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling
Jessica Pagano, Federica Giona, Stefania Beretta, et al.
Current Opinion in Pharmacology (2021) Vol. 56, pp. 93-101
Closed Access | Times Cited: 33
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
Deepa Gautam, Ulhas P. Naik, Meghna U. Naik, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1609-1609
Open Access | Times Cited: 14
Zelquistinel acts at an extracellular binding domain to modulate intracellular calcium inactivation of N-methyl-d-aspartate receptors
Xiaolei Zhang, Yong‐Xin Li, Nils Berglund, et al.
Neuropharmacology (2024) Vol. 259, pp. 110100-110100
Open Access | Times Cited: 4
Is there a risk of esketamine misuse in clinical practice?
Carlos Roncero, M. Merizalde Torres, Néstor Szerman, et al.
Therapeutic Advances in Drug Safety (2025) Vol. 16
Open Access
NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities
Mario García‐Domínguez
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 93-93
Open Access
Effect of SSR504734, a Selective Glycine Transporter Type 1 Inhibitor, on Seizure Thresholds, Neurotransmitter Levels, and Inflammatory Markers in Mice
Nikola Gapińska, Piotr Właź, Elżbieta Wyska, et al.
ACS Chemical Neuroscience (2025)
Open Access
Preliminary pharmacokinetics and in vivo studies indicate analgesic and stress mitigation effects of a novel NMDA receptor modulator
Blaise M. Costa, De'Yana Hines, Nakia Phillip, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103401-103401
Closed Access
Page 1 - Next Page

Scroll to top